185 related articles for article (PubMed ID: 6247719)
1. The Dunning tumors.
Lubaroff DM; Canfield L; Reynolds CW
Prog Clin Biol Res; 1980; 37():243-63. PubMed ID: 6247719
[TBL] [Abstract][Full Text] [Related]
2. An animal model for the study of prostate carcinoma.
Lubaroff DM; Canfield L; Rasmussen GT; Reynolds CW
Natl Cancer Inst Monogr; 1978 Dec; (49):275-81. PubMed ID: 748781
[TBL] [Abstract][Full Text] [Related]
3. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
Isaacs JT; Yu GW; Coffey DS
Invest Urol; 1981 Jul; 19(1):20-3. PubMed ID: 7251319
[TBL] [Abstract][Full Text] [Related]
4. The Nb rat prostatic adenocarcinoma model system.
Drago JR; Goldman LB; Maurer RE
Prog Clin Biol Res; 1980; 37():265-91. PubMed ID: 7384086
[TBL] [Abstract][Full Text] [Related]
5. Experience with an animal model for the study of prostatic carcinoma.
Lubaroff DM; Culp DA
Trans Am Assoc Genitourin Surg; 1977; 69():72-7. PubMed ID: 617916
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
Claflin AJ; Pollack A; Malinin T; Block NL; Irvin GL
J Natl Cancer Inst; 1982 Jul; 69(1):79-87. PubMed ID: 6954325
[TBL] [Abstract][Full Text] [Related]
7. Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.
Halin S; Wikström P; Rudolfsson SH; Stattin P; Doll JA; Crawford SE; Bergh A
Cancer Res; 2004 Aug; 64(16):5664-71. PubMed ID: 15313905
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
9. Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model.
Lowe FC; Isaacs JT
Cancer Res; 1984 Feb; 44(2):744-52. PubMed ID: 6537899
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Pinski J; Reile H; Halmos G; Groot K; Schally AV
Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
[TBL] [Abstract][Full Text] [Related]
11. Growth characteristics and immunogenicity of the R-3327 rat prostate carcinoma.
Coffey DS; Smolev J; Heston WD; Scott WW
Natl Cancer Inst Monogr; 1978 Dec; (49):289-91. PubMed ID: 748782
[TBL] [Abstract][Full Text] [Related]
12. Actin filament organization of the Dunning R3327 rat prostatic adenocarcinoma system: correlation with metastatic potential.
Zachary JM; Cleveland G; Kwock L; Lawrence T; Weissman RM; Nabell L; Fried FA; Staab EV; Risinger MA; Lin S
Cancer Res; 1986 Feb; 46(2):926-32. PubMed ID: 3940653
[TBL] [Abstract][Full Text] [Related]
13. A novel immunological model for the study of prostate cancer.
Sharma N; Luo J; Kirschmann DA; O'Malley Y; Robbins ME; Akporiaye ET; Lubaroff DM; Heidger PM; Hendrix MJ
Cancer Res; 1999 May; 59(10):2271-6. PubMed ID: 10344727
[TBL] [Abstract][Full Text] [Related]
14. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
Ip MM; Milholland RJ; Rosen F
Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
[TBL] [Abstract][Full Text] [Related]
15. Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.
Mohler JL; Partin AW; Isaacs JT; Coffey DS
Cancer Res; 1988 Aug; 48(15):4312-7. PubMed ID: 3390827
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
Smolev JK; Heston WD; Scott WW; Coffey DS
Cancer Treat Rep; 1977; 61(2):273-87. PubMed ID: 872132
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.
Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW
Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244
[TBL] [Abstract][Full Text] [Related]
18. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
Tsingotjidou AS; Ahluwalia R; Zhang X; Conrad H; Emmanouilides C
Int J Oncol; 2003 Dec; 23(6):1569-74. PubMed ID: 14612928
[TBL] [Abstract][Full Text] [Related]
19. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a cloned cell line R3327H-G8-A1 derived from the dunning R3327H rat adenocarcinoma.
Sestili MA; Norris JS; Smith RG
Cancer Res; 1983 May; 43(5):2167-75. PubMed ID: 6299542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
